ClinicalTrials.gov
ClinicalTrials.gov Menu

A Clinical Trial to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 Pfs25-IMX313 and MVA Pfs25-IMX313

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02532049
Recruitment Status : Completed
First Posted : August 25, 2015
Last Update Posted : July 17, 2017
Sponsor:
Information provided by (Responsible Party):
University of Oxford

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 25, 2017
  Actual Study Completion Date : May 25, 2017